Aspirin reduces the risk of ovarian cancer in spite of genetic risk
Those with a genetic predisposition to ovarian cancer may be able to reduce their risk with daily aspirin use, according to a new study...
Those with a genetic predisposition to ovarian cancer may be able to reduce their risk with daily aspirin use, according to a new study...
by Sara Levene
Have you thought about buying an ancestry DNA test as a gift this Christmas? In this article, genetic counsellor, Sara Levene, explains why you should think again…
A screening tool for women with BRCA1 or 2 variants identifies ovarian cancers at an earlier stage, and reduces the need for expensive cancer therapies...
Epigenetics play a crucial role in the development of cancer, according to two studies published in Nature...
by BioNews
by BioNews
The scope of DNA and genetic testing can be an extremely complicated and difficult topic for the average person without a scientific degree to understand. It has become much more accessible since genomic sequencing became cheaper and genetic testing is now deployed in a wide range of health settings...
Hundreds of inherited mutations to BRCA1, a high-risk susceptibility gene for breast and ovarian cancer, have been shown to be harmless...
Stringent NHS genetic testing guidelines may mean that nearly 50 percent of those at risk of cancer are going unchecked, recent evidence suggests...
Cells in cervical smear test samples could be used as an indicator for breast and ovarian cancer, and show promise as tools for monitoring cancer risk...
BioNews, published by the Progress Educational Trust (PET), provides news and comment on genetics, assisted conception, embryo/stem cell research and related areas.